It is a women’s health care biotech spec with a promising pipeline. Jim Cramer learns more about its latest formulation that could be a game changer for many …
source CNBC
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More